Author

Esteban Delgado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Developmental Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

H T Liu· 2 shared Jingjing PangiD· 2 shared Liam FlynniD· 2 shared Long Nguyen Hoang Do· 2 shared Xiaolei LiuiD· 2 shared Jianan ZhaoiD· 1 shared Michael V. AutieriiD· 1 shared Xiaofeng Yang· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

H T Liu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pan-Peroxisome Proliferator-Activated Receptor Agonist IVA337 Alleviates Secondary Lymphedema via Inhibiting TGFβ/SMAD2/3 Signaling Pathway

Jingjing Pang, Long Nguyen Hoang Do, Esteban Delgado, Jianan Zhao, Liam Flynn, H T Liu, Michael V. Autieri, Xiaofeng Yang, Xiaolei Liu

This study shows that IVA337 reduces secondary lymphedema in mice by inhibiting the TGFβ/SMAD2/3 pathway, improving lymphatic function and preventing fibrosis.

Vascular Pharmacology · Aug 29, 2026Peer-reviewedPathology

CXCL12/CXCR4 Governs Lymphatic Valve Formation Through Flow Dependent AKT/FOXO1/FOXC2 Activation

Long Nguyen Hoang Do, Jingjing Pang, Esteban Delgado, Liam Flynn, H T Liu, Xiaolei Liu

This study identifies CXCL12/CXCR4 signaling as critical for lymphatic valve formation through flow-dependent AKT/FOXO1/FOXC2 activation, offering potential therapeutic strategies for lymphedema.

bioRxiv · Jul 22, 2026 · PreprintDevelopmental Biology